Publication:
Antiphospholipid antibodies negativization: time for testing for non-criteria aPL?

dc.contributor.authorRadin, M
dc.contributor.authorCecchi, I
dc.contributor.authorPerez-Sanchez, C
dc.date.accessioned2023-01-25T09:46:21Z
dc.date.available2023-01-25T09:46:21Z
dc.date.issued2017-04-26
dc.description.abstractSir,While we read with interest the recent article byComarmond and colleagues 1 about the cessation oforal anticoagulants in antiphospholipid syndrome(APS), we do feel there are some points of the studystill open for discussion.Comarmond and colleagues 1 describe 10 patientswith prolonged disappearance of antiphospholipidantibodies (aPL) that were stopped anticoagulationtherapy. After a median duration of follow-up of 19months since the cessation of oral anticoagulants,one out of 10 patients relapsed developing pulmon-ary embolism.
dc.description.versionSi
dc.identifier.citationRadin M, Cecchi I, Pérez-Sánchez C. Antiphospholipid antibodies negativization: time for testing for non-criteria aPL? Lupus. 2017 Nov;26(13):1457-1458
dc.identifier.doi10.1177/0961203317711014
dc.identifier.essn1477-0962
dc.identifier.pmid28530465
dc.identifier.urihttp://hdl.handle.net/10668/11215
dc.issue.number13
dc.journal.titleLupus
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number1457-1458
dc.provenanceRealizada la curación de contenido 22/08/2024
dc.publisherSage Publications
dc.pubmedtypeJournal Article
dc.pubmedtypeComment
dc.relation.publisherversionhttps://journals.sagepub.com/doi/10.1177/0961203317711014?url_ver=Z39.882003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
dc.subjectAnticoagulants
dc.subjectFollow-up studies
dc.subjectEmbolism
dc.subject.decsAnticoagulantes
dc.subject.decsAnticuerpos antifosfolípidos
dc.subject.decsLupus eritematoso sistémico
dc.subject.decsSíndrome antifosfolípido
dc.subject.meshAntibodies, antiphospholipid
dc.subject.meshAnticoagulants
dc.subject.meshAntiphospholipid syndrome
dc.subject.meshHumans
dc.subject.meshLupus erythematosus, systemic
dc.titleAntiphospholipid antibodies negativization: time for testing for non-criteria aPL?
dc.typeresearch article
dc.volume.number26
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format